MXLGX
Price
$9.16
Change
+$0.04 (+0.44%)
Updated
Apr 17 closing price
Net Assets
1.49B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

MXLGX vs VIGRX

Header iconMXLGX vs VIGRX Comparison
Open Charts MXLGX vs VIGRXBanner chart's image
Empower Large Cap Growth I
Price$9.16
Change+$0.04 (+0.44%)
VolumeN/A
Net Assets1.49B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
MXLGX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MXLGX vs. VIGRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXLGX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. MXLGX (1.49B). VIGRX pays higher dividends than MXLGX: VIGRX (0.39) vs MXLGX (0.00). MXLGX was incepted earlier than VIGRX: MXLGX (22 years) vs VIGRX (32 years). MXLGX (1.00) is less costly to investors than VIGRX (0.17). MXLGX is a more actively managed with annual turnover of: 46.00 vs. VIGRX (5.00). MXLGX has a lower initial minimum investment than VIGRX: MXLGX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. MXLGX (-7.60). VIGRX return over 5 years is better than : 99.21 vs. MXLGX (1.70).
MXLGXVIGRXMXLGX / VIGRX
Total Expense Ratio0.980.17576%
Annual Report Gross Expense Ratio1.000.17588%
Fund Existence22 years32 years-
Gain YTD-11.628-14.32681%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.49B261B1%
Annual Yield % from dividends0.000.39-
Returns for 1 year-7.606.01-126%
Returns for 3 years6.8030.3322%
Returns for 5 years1.7099.212%
Returns for 10 years-2.05223.84-1%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics